June 14, 2024

1317-P: Novel Clusters of Prediabetes Help to Better Identify People at Risk for Diabetes-Associated Complications

Key Points

Key points are not available for this paper at this time.

Abstract

Introduction Springer Medizin Verlag GmbH. M. Roshan: None. Z. Kender: None. S. Kopf: Speaker's Bureau; Lilly Diabetes, Bayer Inc. J. Szendroedi: None. A. Sulaj: None.

Mark Helpful

Bookmark

Relay

Mark Helpful

Bookmark

Relay

Cite This Study

Ansmann et al. (Fri,) studied this question.

synapsesocial.com/papers/68e64c51b6db6435875dd470 https://doi.org/https://doi.org/10.2337/db24-1317-p

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

12302-P: Overall and Site-Specific Tumor Incidence and Prevalence Differ across Prediabetes Subphenotypes2026
2Beyond Glucose—Rethinking Prediabetes for Precision Prevention2025 · 11 citations
31387-P: Prediabetes Subgroups, Type 2 Diabetes Risk, and Differential Intervention Effects2024
42335-P: Metabolomic Analysis Reveals That Prediabetes Subgroups Have Different Likelihoods of T2D Onset: A Definition, Etiology, and Function: Integration to Enhance T2D Treatment (DEFINE-T2D) Consortium Analysis2026
5Data-driven subgroups for 3-year risk stratification of incident diabetes and complications in diabetes-free Chinese adults2026